Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01752413 · ClinicalTrials.gov registry record · NA

Iron Depletion and Replacement in Blood Donors

A NA study of Anemia, sponsored by Memorial Blood Centers, Minnesota.

Completed
Registry status
NA
Development phase
197
Enrollment target
1
Study location

NCT01752413: Completed NA study of Anemia, sponsored by Memorial Blood Centers, Minnesota.

NCT01752413 is a NA study of Anemia that has completed, run by Memorial Blood Centers, Minnesota. The registered enrollment target is 197 participants, below the 425-participant average among 72 other Anemia trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01752413, a NA study of Anemia, has completed, sponsored by Memorial Blood Centers, Minnesota.

COMPLETED
Registry status
NA
Development phase
197 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine (1) the role of ferritin testing to screen for iron depletion in donors at risk of low iron levels (2) the effectiveness of oral iron replacement therapy on the repletion of iron stores in donors, and (3) the feasibility of blood centers to routinely distribute oral iron replacement therapy to donors.

Primary Outcome

Subject self reported habits for taking iron supplement or iron rich diet and severity of gastrointestinal complaints (minimal-1 to severe-5). GI complaints were not separated by type for analysis.

Conditions Studied

Interventions

  • BEHAVIORAL Nutrition counseling
  • DIETARY_SUPPLEMENT Ferrous gluconate 325mg

Study Locations (1)

Minnesota

  • Memorial Blood Centers - Saint Paul

Trial Details

FieldValue
Enrollment Target 197 participants
Start Date 2012-12
Est. Completion 2014-11
Phase NA

What the finished NCT01752413 record still lists

NCT01752413 is an interventional study that assigns participants to a tested intervention. The registered 197 participants enrollment target is mid-sized for trials with a published cap, below the 425-participant average among 72 other Anemia trials with a reported enrollment target (54% lower).

The record links to 1 condition, with Anemia appearing as the primary indexed condition, and to 2 interventions - of which Nutrition counseling is the first listed.

NCT01752413 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT01752413 about?

NCT01752413 is a clinical study titled "Iron Depletion and Replacement in Blood Donors". The purpose of this study is to determine (1) the role of ferritin testing to screen for iron depletion in donors at risk of low iron levels (2) the effectiveness of oral iron replacement therapy on the repletion of iron stores in donors, and (3) the feasibility of blood centers to routinely distrib...

What is the current status of trial NCT01752413?

This trial is currently completed. It is a NA study. The enrollment target is 197 participants. The study started on 2012-12. Estimated completion is 2014-11.

What conditions does trial NCT01752413 study?

This clinical trial studies the following conditions: Anemia.

What interventions are being tested in trial NCT01752413?

The interventions under investigation include: Nutrition counseling (BEHAVIORAL), Ferrous gluconate 325mg (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01752413?

This trial is sponsored by Memorial Blood Centers, Minnesota, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01752413 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01752413's enrollment target sits among peer trials

197 34th of 72 higher than 39 of 72 other Anemia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04219254 · 197 participants · Phase 1

    A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

  • NCT06173778 · 197 participants · Phase 2

    Semaglutide for Post-Smoking Cessation Weight Management

  • NCT05203328 · 198 participants · NA

    Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy

  • NCT05426967 · 198 participants · NA

    rTMS for Military TBI-related Depression

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01752413, the US trial registry maintained by the National Library of Medicine. NCT01752413 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.